Skip to content

Development and Application of a Medication Adherence Intervention Program for Elderly Patients with Multimorbidity Based on User Profiling

Development and Application of a Medication Adherence Intervention Program for Elderly Patients with Multimorbidity Based on User Profiling

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127647
Enrollment
Unknown
Registered
2026-07-03
Start date
2026-07-15
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multimorbidity

Interventions

intervention group:The transitional intervention was delivered over 8 weeks via online platforms including WeChat and telephone. Core components included regular follow-up via WeChat, providing person
family members were also engaged to provide supervision and emotional support, and support strategies were adjusted in a timely manner based on dynamic assessments of adherence and self-management cap
Control group:Patients receive routine care and a telephone follow?up one week after discharge.

Sponsors

Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 60 years; 2. Diagnosed with at least two chronic diseases at a secondary or tertiary hospital; 3. Prescribed at least one long-term medication (duration >= 6 months) before admission and after discharge; 4. Permanent resident of Fuzhou urban area, with no plans to travel abroad or leave the city in the next three months; 5. Own a smartphone and be able to use WeChat; 6. No communication barriers; 7. Willing to participate voluntarily in this study.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment or mental illness that prevents understanding of study requirements; 2. Critically ill and/or at end-stage of disease; 3. Complicated with severe cardiac, hepatic, or renal insufficiency, or malignant tumors; 4. Previously participated or currently participating in other clinical trials that may affect the results of this study.

Design outcomes

Primary

MeasureTime frame
Medication Adherence;

Secondary

MeasureTime frame
Self-efficacy for Appropriate Medication Use;Beliefs about Medicines;Medication Literacy;Social Support;

Countries

China

Contacts

Public ContactTing Lin

Fujian Medical University

fjswbhjx@sina.com+86 136 0953 2214

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026